220 related articles for article (PubMed ID: 29845536)
1. Animal Models for Dengue and Zika Vaccine Development.
Alves Dos Santos E; Fink K
Adv Exp Med Biol; 2018; 1062():215-239. PubMed ID: 29845536
[TBL] [Abstract][Full Text] [Related]
2. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.
Katzelnick LC; Bos S; Harris E
Curr Opin Virol; 2020 Aug; 43():59-70. PubMed ID: 32979816
[TBL] [Abstract][Full Text] [Related]
3. Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus.
Baldwin WR; Giebler HA; Stovall JL; Young G; Bohning KJ; Dean HJ; Livengood JA; Huang CY
Nat Commun; 2021 Dec; 12(1):7320. PubMed ID: 34916486
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of domain III proteins from Dengue and Zika viruses.
Corzo-Gómez J; García-Cordero J; Montes Gómez AE; Bernal-Siria K; Namorado-Tónix K; Gutierrez-Castañeda B; Cedillo-Barrón L
Protein Expr Purif; 2019 Oct; 162():38-43. PubMed ID: 31112759
[TBL] [Abstract][Full Text] [Related]
5. T Cell Immunity and Zika Virus Vaccine Development.
Lima NS; Rolland M; Modjarrad K; Trautmann L
Trends Immunol; 2017 Aug; 38(8):594-605. PubMed ID: 28579320
[TBL] [Abstract][Full Text] [Related]
6. Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine.
Wang R; Gao N; Li Y; Fan D; Zhen Z; Feng K; Chen H; An J
Front Cell Infect Microbiol; 2019; 9():147. PubMed ID: 31139577
[TBL] [Abstract][Full Text] [Related]
7. Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.
Masel J; McCracken MK; Gleeson T; Morrison B; Rutherford G; Imrie A; Jarman RG; Koren M; Pollett S
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007060. PubMed ID: 30682026
[TBL] [Abstract][Full Text] [Related]
8. Dengue in Brazil in 2017: what happened?
Lopes TRR; Silva CS; Pastor AF; Silva Júnior JVJ
Rev Inst Med Trop Sao Paulo; 2018 Aug; 60():e43. PubMed ID: 30133603
[No Abstract] [Full Text] [Related]
9. Immune Response to Dengue and Zika.
Ngono AE; Shresta S
Annu Rev Immunol; 2018 Apr; 36():279-308. PubMed ID: 29345964
[TBL] [Abstract][Full Text] [Related]
10. Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development.
Osuna CE; Whitney JB
J Infect Dis; 2017 Dec; 216(suppl_10):S928-S934. PubMed ID: 29267926
[TBL] [Abstract][Full Text] [Related]
11. Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?
Wen J; Shresta S
Curr Opin Immunol; 2019 Aug; 59():1-8. PubMed ID: 30884384
[TBL] [Abstract][Full Text] [Related]
12. Specificity of Dengue NS1 Antigen in Differential Diagnosis of Dengue and Zika Virus Infection.
Matheus S; Boukhari R; Labeau B; Ernault V; Bremand L; Kazanji M; Rousset D
Emerg Infect Dis; 2016 Sep; 22(9):1691-3. PubMed ID: 27347853
[No Abstract] [Full Text] [Related]
13. ADE-ing and Abetting Zika.
Wen J; Shresta S
Cell Host Microbe; 2017 May; 21(5):557-558. PubMed ID: 28494235
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017.
Perng GC; Ho TC; Shih HI; Lee CH; Huang PW; Chung CH; Ko NY; Ko WC; Chien YW
Emerg Infect Dis; 2019 Apr; 25(4):814-816. PubMed ID: 30882327
[TBL] [Abstract][Full Text] [Related]
15. Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.
López-Camacho C; Abbink P; Larocca RA; Dejnirattisai W; Boyd M; Badamchi-Zadeh A; Wallace ZR; Doig J; Velazquez RS; Neto RDL; Coelho DF; Kim YC; Donald CL; Owsianka A; De Lorenzo G; Kohl A; Gilbert SC; Dorrell L; Mongkolsapaya J; Patel AH; Screaton GR; Barouch DH; Hill AVS; Reyes-Sandoval A
Nat Commun; 2018 Jun; 9(1):2441. PubMed ID: 29934593
[TBL] [Abstract][Full Text] [Related]
16. Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro.
Kawiecki AB; Christofferson RC
J Infect Dis; 2016 Nov; 214(9):1357-1360. PubMed ID: 27521359
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine.
In HJ; Lee YH; Jang S; Lim HJ; Kim MY; Kim JA; Yoo JS; Chung GT; Kim YJ
Virology; 2020 Oct; 549():25-31. PubMed ID: 32818729
[TBL] [Abstract][Full Text] [Related]
18. Serological evidence of Zika virus infection in non-human primates in Zambia.
Wastika CE; Sasaki M; Yoshii K; Anindita PD; Hang'ombe BM; Mweene AS; Kobayashi S; Kariwa H; Carr MJ; Hall WW; Eshita Y; Orba Y; Sawa H
Arch Virol; 2019 Aug; 164(8):2165-2170. PubMed ID: 31154511
[TBL] [Abstract][Full Text] [Related]
19. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of Parameters for Zika and Dengue Virus Infections, Singapore.
Ho HJ; Wong JGX; Mar Kyaw W; Lye DC; Leo YS; Chow A
Emerg Infect Dis; 2017 Dec; 23(12):2085-2088. PubMed ID: 29148371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
